{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:01:57Z","timestamp":1784257317511,"version":"3.55.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.neurol.2020.11.012","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T10:11:14Z","timestamp":1617185474000},"page":"924-934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Severe migraine and its control: A proposal for definitions and consequences for care"],"prefix":"10.1016","volume":"177","author":[{"given":"Anne","family":"Donnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Ducros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Radat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar","family":"Allaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Chouette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Lanteri-Minet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurol.2020.11.012_bib0410","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1468-1331.2006.01184.x","article-title":"Epidemiology of headache in Europe","volume":"13","author":"Stovner","year":"2006","journal-title":"Eur J Neurol"},{"issue":"10100","key":"10.1016\/j.neurol.2020.11.012_bib0415","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"2016 Disease","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.neurol.2020.11.012_bib0420","first-page":"616","article-title":"Evaluation de la migraine","volume":"58","author":"Radat","year":"2008","journal-title":"Rev Prat"},{"issue":"5","key":"10.1016\/j.neurol.2020.11.012_bib0425","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurol.2020.11.012_bib0430","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/head.12774","article-title":"Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study","volume":"56","author":"Dodick","year":"2016","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.neurol.2020.11.012_bib0435","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s10194-018-0839-1","article-title":"Poor medical care for people with migraine in Europe - evidence from the Eurolight study","volume":"19","author":"Katsarava","year":"2018","journal-title":"The journal of headache and pain"},{"issue":"1","key":"10.1016\/j.neurol.2020.11.012_bib0440","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s10194-018-0846-2","article-title":"Migraine is first cause of disability in under 50s: will health politicians now take notice?","volume":"19","author":"Steiner","year":"2018","journal-title":"The journal of headache and pain"},{"issue":"3","key":"10.1016\/j.neurol.2020.11.012_bib0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212785","article-title":"Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis","volume":"14","author":"Jackson","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.neurol.2020.11.012_bib0450","article-title":"Topiramate for the prophylaxis of episodic migraine in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.neurol.2020.11.012_bib0455","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027953","article-title":"Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine","volume":"9","author":"Herd","year":"2019","journal-title":"BMJ Open"},{"issue":"10210","key":"10.1016\/j.neurol.2020.11.012_bib0460","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(19)32504-8","article-title":"Targeting calcitonin gene-related peptide: a new era in migraine therapy","volume":"394","author":"Charles","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"12","key":"10.1016\/j.neurol.2020.11.012_bib0465","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1468-2982.2007.01426.x","article-title":"The GRIM2005 study of migraine consultation in France I","volume":"27","author":"Lant\u00e9ri-Minet","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2020.11.012_bib0470","series-title":"Headache disorders: Fact sheet","author":"World Health Organization","year":"2016"},{"issue":"4","key":"10.1016\/j.neurol.2020.11.012_bib0475","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10194-011-0320-x","article-title":"Recommendations for headache service organisation and delivery in Europe","volume":"12","author":"Steiner","year":"2011","journal-title":"The journal of headache and pain"},{"issue":"2","key":"10.1016\/j.neurol.2020.11.012_bib0480","doi-asserted-by":"crossref","first-page":"103","DOI":"10.17925\/ENR.2018.13.2.103","article-title":"Management of migraine and the accessibility of specialist care\u2013Findings from a multi-national assessment of 28 healthcare networks","volume":"13","author":"Kainth","year":"2018","journal-title":"Eur Neurol Rev"},{"issue":"1","key":"10.1016\/j.neurol.2020.11.012_bib0485","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s10194-018-0946-z","article-title":"My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed","volume":"19","author":"Martelletti","year":"2018","journal-title":"The journal of headache and pain"},{"issue":"1","key":"10.1016\/j.neurol.2020.11.012_bib0490","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s10194-019-1040-x","article-title":"Identifying and managing refractory migraine: barriers and opportunities?","volume":"20","author":"D\u2019Antona","year":"2019","journal-title":"The journal of headache and pain"},{"issue":"Suppl 1","key":"10.1016\/j.neurol.2020.11.012_bib0495","article-title":"Development of the Migraine Symptom Severity Score (MSSS): A Latent Variable Model for Migraine Definition","volume":"50","author":"Serrano","year":"2010","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.neurol.2020.11.012_bib0500","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1046\/j.1526-4610.2003.03105.x","article-title":"Assessing the severity of migraine: development of the MIGSEV scale","volume":"43","author":"El Hasnaoui","year":"2003","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.neurol.2020.11.012_bib0505","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1526-4610.2007.00806.x","article-title":"Intrapatient variability of migraine attacks: stability analysis of the MIGSEV scale","volume":"48","author":"Baha","year":"2008","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.neurol.2020.11.012_bib0510","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-2982.1999.019002107.x","article-title":"Reliability of the migraine disability assessment score in a population-based sample of headache sufferers","volume":"19","author":"Stewart","year":"1999","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/j.neurol.2020.11.012_bib0515","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1023\/A:1026119331193","article-title":"A six-item short-form survey for measuring headache impact: the HIT-6","volume":"12","author":"Kosinski","year":"2003","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.neurol.2020.11.012_bib0520","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12883-019-1284-8","article-title":"Global assessment of migraine severity measure: preliminary evidence of construct validity","volume":"19","author":"Sajobi","year":"2019","journal-title":"BMC neurology"},{"issue":"8","key":"10.1016\/j.neurol.2020.11.012_bib0525","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1046\/j.1468-2982.1997.1708863.x","article-title":"Frequency of severe attacks in migraine sufferers of the Gazel cohort","volume":"17","author":"Michel","year":"1997","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.neurol.2020.11.012_bib0530","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1468-2982.2008.01718.x","article-title":"The GRIM2005 study of migraine consultation in France. III: Psychological features of subjects with migraine","volume":"29","author":"Radat","year":"2009","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.neurol.2020.11.012_bib0535","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/head.13021","article-title":"Psychological Factors Associated With Chronic Migraine and Severe Migraine-Related Disability: An Observational Study in a Tertiary Headache Center","volume":"57","author":"Seng","year":"2017","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.neurol.2020.11.012_bib0540","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/WCO.0000000000000309","article-title":"Understanding migraine and psychiatric comorbidity","volume":"29","author":"Seng","year":"2016","journal-title":"Current opinion in neurology"},{"issue":"2","key":"10.1016\/j.neurol.2020.11.012_bib0545","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s13760-018-1050-5","article-title":"Personality disorders are associated with more severe forms of migraine","volume":"119","author":"Yang","year":"2019","journal-title":"Acta neurologica Belgica"},{"issue":"8","key":"10.1016\/j.neurol.2020.11.012_bib0550","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1007\/s00415-012-6725-x","article-title":"Psychiatric comorbidities of episodic and chronic migraine","volume":"260","author":"Buse","year":"2013","journal-title":"Journal of neurology"},{"issue":"10","key":"10.1016\/j.neurol.2020.11.012_bib0555","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1468-2982.2007.01420.x","article-title":"Impaired functioning and quality of life in severe migraine: the role of catastrophizing and associated symptoms","volume":"27","author":"Holroyd","year":"2007","journal-title":"Cephalalgia"},{"issue":"6","key":"10.1016\/j.neurol.2020.11.012_bib0560","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11916-015-0498-8","article-title":"Improving medication adherence in migraine treatment","volume":"19","author":"Seng","year":"2015","journal-title":"Curr Pain Headache Rep"},{"issue":"Suppl 1","key":"10.1016\/j.neurol.2020.11.012_bib0565","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1007\/s11739-010-0461-y","article-title":"Chronic headaches and medication overuse","volume":"5","author":"Geppetti","year":"2010","journal-title":"Internal and emergency medicine"},{"issue":"8","key":"10.1016\/j.neurol.2020.11.012_bib0570","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/head.13613","article-title":"Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study","volume":"59","author":"Buse","year":"2019","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.neurol.2020.11.012_bib0575","doi-asserted-by":"crossref","first-page":"89","DOI":"10.15256\/joc.2017.7.114","article-title":"Chronic migraine, comorbidity, and socioeconomic deprivation: cross-sectional analysis of a large nationally representative primary care database","volume":"7","author":"McLean","year":"2017","journal-title":"Journal of comorbidity"},{"issue":"4","key":"10.1016\/j.neurol.2020.11.012_bib0580","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/head.13028","article-title":"Family Impact of Migraine: Development of the Impact of Migraine on Partners and Adolescent Children (IMPAC) Scale","volume":"57","author":"Lipton","year":"2017","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.neurol.2020.11.012_bib0585","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/0333102415570492","article-title":"The association between candidate migraine susceptibility loci and severe migraine phenotype in a clinical sample","volume":"36","author":"Esserlind","year":"2016","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.neurol.2020.11.012_bib0590","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/0333102418783295","article-title":"Linking migraine frequency with family history of migraine","volume":"39","author":"Pelzer","year":"2019","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.neurol.2020.11.012_bib0595","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.neuron.2018.04.014","article-title":"Common Variant Burden Contributes to the Familial Aggregation of Migraine in 1589 Families","volume":"98","author":"Gormley","year":"2018","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.neurol.2020.11.012_bib0600","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1468-2982.2004.00816.x","article-title":"Variability of reported headache symptoms and diagnosis of migraine at 12 months","volume":"25","author":"Nachit-Ouinekh","year":"2005","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/j.neurol.2020.11.012_bib0605","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1526-4610.2009.01502.x","article-title":"The course of frequent episodic migraine in a large headache clinic population: a 12-year retrospective follow-up study","volume":"49","author":"Dahlof","year":"2009","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.neurol.2020.11.012_bib0610","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s10194-017-0787-1","article-title":"Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design","volume":"18","author":"Serrano","year":"2017","journal-title":"The journal of headache and pain"},{"issue":"1","key":"10.1016\/j.neurol.2020.11.012_bib0615","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1468-2982.1995.1501031.x","article-title":"Migraine patients experience poorer subjective well-being\/quality of life even between attacks","volume":"15","author":"Dahlof","year":"1995","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2020.11.012_bib0620","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s10194-016-0599-8","article-title":"Interictal burden attributable to episodic headache: findings from the Eurolight project","volume":"17","author":"Lampl","year":"2016","journal-title":"The journal of headache and pain"},{"issue":"1","key":"10.1016\/j.neurol.2020.11.012_bib0625","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1468-2982.2007.01461.x","article-title":"MIDAS and HIT-6 French translation: reliability and correlation between tests","volume":"28","author":"Magnoux","year":"2008","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.neurol.2020.11.012_bib0630","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1526-4610.2009.01544.x","article-title":"HIT-6 and MIDAS as measures of headache disability in a headache referral population","volume":"50","author":"Sauro","year":"2010","journal-title":"Headache"},{"issue":"Suppl 1","key":"10.1016\/j.neurol.2020.11.012_bib0635","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00023210-200216001-00003","article-title":"Global trends in migraine care: results from the MAZE survey","volume":"16","author":"Brandes","year":"2002","journal-title":"CNS drugs"},{"issue":"3","key":"10.1016\/j.neurol.2020.11.012_bib0640","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0333102410379890","article-title":"Validation of the Headache Impact Test (HIT-6) across episodic and chronic migraine","volume":"31","author":"Yang","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2020.11.012_bib0645","series-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"issue":"8","key":"10.1016\/j.neurol.2020.11.012_bib0650","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1177\/0333102418779543","article-title":"Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial","volume":"38","author":"Skljarevski","year":"2018","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.neurol.2020.11.012_bib0655","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/jamaneurol.2018.1212","article-title":"Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial","volume":"75","author":"Stauffer","year":"2018","journal-title":"JAMA neurology"},{"key":"10.1016\/j.neurol.2020.11.012_bib0660","series-title":"Prise en charge diagnostique et th\u00e9rapeutique de la migraine chez l\u2019adulte et chez l\u2019enfant","author":"Agence Nationale d\u2019Accr\u00e9ditation et d\u2019\u00c9valuation en Sant\u00e9","year":"2002"},{"key":"10.1016\/j.neurol.2020.11.012_bib0665","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1129-2377-15-2","article-title":"Revised French guidelines for the diagnosis and management of migraine in adults and children","volume":"15","author":"Lant\u00e9ri-Minet","year":"2014","journal-title":"The journal of headache and pain"},{"issue":"7","key":"10.1016\/j.neurol.2020.11.012_bib0670","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1468-2982.2008.01786.x","article-title":"Validity and reliability of the Migraine-Treatment Optimization Questionnaire","volume":"29","author":"Lipton","year":"2009","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.neurol.2020.11.012_bib0675","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1526-4610.2006.00403.x","article-title":"Reliability, validity, and clinical utility of the Migraine-ACT questionnaire","volume":"46","author":"Kilminster","year":"2006","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.neurol.2020.11.012_bib0680","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1185\/030079904125004079","article-title":"Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire","volume":"20","author":"Dowson","year":"2004","journal-title":"Current medical research and opinion"},{"issue":"10","key":"10.1016\/j.neurol.2020.11.012_bib0685","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1046\/j.1526-4610.2002.02230.x","article-title":"Reliability and validity of the migraine therapy assessment questionnaire","volume":"42","author":"Chatterton","year":"2002","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.neurol.2020.11.012_bib0690","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s10194-018-0842-6","article-title":"The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility","volume":"19","author":"Steiner","year":"2018","journal-title":"The journal of headache and pain"},{"issue":"6","key":"10.1016\/j.neurol.2020.11.012_bib0695","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1526-4610.2008.01132.x","article-title":"Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society","volume":"48","author":"Schulman","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.neurol.2020.11.012_bib0700","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-020-01130-5","article-title":"European Headache Federation consensus on the definition of resistant and refractory migraine","author":"Sacco","year":"2020","journal-title":"The journal of headache and pain"},{"key":"10.1016\/j.neurol.2020.11.012_bib0705","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2377-11-94","article-title":"Refractory migraine in a headache clinic population","volume":"11","author":"Irimia","year":"2011","journal-title":"BMC neurology"},{"issue":"9","key":"10.1016\/j.neurol.2020.11.012_bib0710","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The International Classification of Headache Disorders, 3rd edition (beta version)","volume":"33","author":"Headache Classification Committee of the International Headache Society","year":"2013","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.neurol.2020.11.012_bib0715","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ejp.692","article-title":"Cervical 10kHz spinal cord stimulation in the management of chronic, medically refractory migraine: A prospective, open-label, exploratory study","volume":"20","author":"Arcioni","year":"2016","journal-title":"European journal of pain (London, England)"},{"issue":"Suppl 1","key":"10.1016\/j.neurol.2020.11.012_bib0720","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1007\/s10072-008-0888-3","article-title":"When should \u201cchronic migraine\u201d patients be considered \u201crefractory\u201d to pharmacological prophylaxis?","volume":"29","author":"D\u2019Amico","year":"2008","journal-title":"Neurol Sci"},{"issue":"10","key":"10.1016\/j.neurol.2020.11.012_bib0725","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/j.1526-4610.2010.01794.x","article-title":"Commentary from the Refractory Headache Special Interest Section on defining the pharmacologically intractable headache for clinical trials and clinical practice","volume":"50","author":"Schulman","year":"2010","journal-title":"Headache"},{"issue":"9","key":"10.1016\/j.neurol.2020.11.012_bib0730","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1526-4610.2010.01764.x","article-title":"Defining the pharmacologically intractable headache for clinical trials and clinical practice","volume":"50","author":"Silberstein","year":"2010","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.neurol.2020.11.012_bib0735","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0333102416636055","article-title":"When does chronic migraine strike? A clinical comparison of migraine according to the headache days suffered per month","volume":"37","author":"Torres-Ferrus","year":"2017","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.neurol.2020.11.012_bib0740","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/0333102419877171","article-title":"Proposed new diagnostic criteria for chronic migraine","volume":"40","author":"Chalmer","year":"2020","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.neurol.2020.11.012_bib0745","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neurol.2013.09.006","article-title":"D\u00e9marche diagnostique g\u00e9n\u00e9rale devant une c\u00e9phal\u00e9e chronique quotidienne (CCQ)\u2013Prise en charge d\u2019une CCQ chez le migraineux: c\u00e9phal\u00e9e par abus m\u00e9dicamenteux et migraine chronique\/Recommandations de la SFEMC, ANLLF et SFETD","volume":"170","author":"Lant\u00e9ri-Minet","year":"2014","journal-title":"Rev Neurol (Paris)"},{"issue":"1","key":"10.1016\/j.neurol.2020.11.012_bib0750","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1526-4610.2011.02046.x","article-title":"Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study","volume":"52","author":"Buse","year":"2012","journal-title":"Headache"},{"issue":"8","key":"10.1016\/j.neurol.2020.11.012_bib0755","first-page":"943","article-title":"Topiramate in migraine prophylaxis\u2013results from a placebo-controlled trial with propranolol as an active control","volume":"251","author":"Diener","year":"2004","journal-title":"Journal of neurology"},{"issue":"4","key":"10.1016\/j.neurol.2020.11.012_bib0760","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.61.4.490","article-title":"Topiramate in migraine prevention: results of a large controlled trial","volume":"61","author":"Silberstein","year":"2004","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2020.11.012_bib0765","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.291.8.965","article-title":"Topiramate for migraine prevention: a randomized controlled trial","volume":"291","author":"Brandes","year":"2004","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.neurol.2020.11.012_bib0770","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11916-018-0734-0","article-title":"Triggers, Protectors, and Predictors in Episodic Migraine","volume":"22","author":"Marmura","year":"2018","journal-title":"Current pain and headache reports"},{"issue":"4","key":"10.1016\/j.neurol.2020.11.012_bib0775","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","article-title":"Migraine: Epidemiology, Burden, and Comorbidity","volume":"37","author":"Burch","year":"2019","journal-title":"Neurol Clin"},{"key":"10.1016\/j.neurol.2020.11.012_bib0780","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1129-2377-14-81","article-title":"Probable medications overuse headaches: validation of a brief easy-to-use screening tool in a headache centre","volume":"14","author":"Dousset","year":"2013","journal-title":"The journal of headache and pain"},{"issue":"2","key":"10.1016\/j.neurol.2020.11.012_bib0785","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1526-4610.2006.00331.x","article-title":"Construction of a medication dependence questionnaire in headache patients (MDQ-H) validation of the French version","volume":"46","author":"Radat","year":"2006","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.neurol.2020.11.012_bib0790","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","article-title":"Research guidelines for the Delphi survey technique","volume":"32","author":"Hasson","year":"2000","journal-title":"J Adv Nurs"},{"issue":"4","key":"10.1016\/j.neurol.2020.11.012_bib0795","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/09638288.2011.607211","article-title":"Migraine\u2013more than a headache: women's experiences of living with migraine","volume":"34","author":"Rutberg","year":"2012","journal-title":"Disability and rehabilitation"},{"key":"10.1016\/j.neurol.2020.11.012_bib0800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3402\/qhw.v8i0.19900","article-title":"Travelling along a road with obstacles: experiences of managing life to feel well while living with migraine","volume":"8","author":"Rutberg","year":"2013","journal-title":"International journal of qualitative studies on health and well-being"},{"issue":"4","key":"10.1016\/j.neurol.2020.11.012_bib0805","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/08870446.2012.731059","article-title":"Illness perception of migraineurs from the general population","volume":"28","author":"Radat","year":"2013","journal-title":"Psychol Health"},{"issue":"10","key":"10.1016\/j.neurol.2020.11.012_bib0810","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1177\/0333102409355661","article-title":"Clinical determinants of migraine preventive treatment: contribution of SMILE, an observational survey of primary care migraine management in France","volume":"30","author":"Valade","year":"2010","journal-title":"Cephalalgia"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378721004574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378721004574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:43:50Z","timestamp":1758519830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378721004574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":81,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0035378721004574"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2020.11.012","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe migraine and its control: A proposal for definitions and consequences for care","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2020.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}